Prime Capital Investment Advisors, LLC
Position in IBRX — ImmunityBio, Inc.
CIK 1731446
OVERLAND PARK, KS
Position in IBRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$144,732
New position
Shares Held
18,870
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prime Capital Investment Advisors, LLC holds $14,447,509 across 15 Biotechnology names. IBRX ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,916 | $10,752,058 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,334 | $1,042,224 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
15,826 | $992,290 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
11,343 | $369,101 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
3,971 | $298,182 | |
| 6 | IMTX |
Immatics N.V.
|
30,000 | $295,200 | |
| 7 | MRNA |
Moderna, Inc.
|
4,639 | $235,661 | |
| 8 | IBRX |
ImmunityBio, Inc.
This page
|
18,870 | $144,732 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $144,732 | 18,870 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||